TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/08/2025
Back to search
Official data from USPTO
SELTOLZA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
12/10/2025
Trademark type
Word
Nice classes
5, 44
Filing date
07/01/2021
Registration date
08/02/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/02/2022
Last transaction
12/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
16
Owner location
LOUISVILLE, KY
Examiner
GREEN,ASHLEY ELIZABETH
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
USWM CT, LLC
Adaptimmune Limited
Representatives
Amy B. Berge Gray Ice Higdon, PLLC
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cell therapy pharmaceutical preparations; pharmaceutical immunotherapy preparations for use in cancer treatment; T-cell receptors in the nature of pharmaceutical preparations for use in cancer treatment; pharmaceutical immunotherapy preparations comprising engineered T-cell receptors for use in cancer treatment; pharmaceutical immunotherapy preparations comprising genes encoding engineered T-cell receptors for use in cancer treatment
Class 44
Cell therapy medical treatment services; medical immunotherapy services; medical treatment and immune-therapy comprising harvesting a patient's white blood cellscombining white blood cells with an engineered T-cell receptor therapeutictransducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient
Publications
History of USPTO decisions and trademark events.
27 publications found
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
12/08/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/08/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/08/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/08/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/08/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/03/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/02/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/02/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/17/2022
PUBO
PUBLISHED FOR OPPOSITION
05/17/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/27/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/14/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/12/2022
ALIE
ASSIGNED TO LIE
04/12/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/07/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/24/2022
GNSL
LETTER OF SUSPENSION E-MAILED
03/24/2022
CNSL
SUSPENSION LETTER WRITTEN
03/24/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
03/24/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/24/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
03/24/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/24/2022
DOCK
ASSIGNED TO EXAMINER
03/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/13/2021
NWAP
NEW APPLICATION ENTERED
07/05/2021
Continuous trademark protection
Get notified about every new filing that threatens SELTOLZA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.